GlassScriptPhysician profile
Dale B Smith
NPI 1083660369
$1,609.21
in general payments reported to CMS, 2019-2025
17 companies · $364 in 2025
The $364 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $234 · 2020: $195 · 2021: $145 · 2022: $174 · 2023: $295 · 2024: $202 · 2025: $364.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $766 · Education: $94.63.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $765.77 |
| Education | $94.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $264.24 | 2020-2025 | Dupixent |
| Optinose US, INC. | $238.50 | 2020-2024 | |
| Genzyme Corporation | $217.98 | 2019-2024 | |
| Allergan, INC. | $205.36 | 2019-2022 | |
| Glaxosmithkline, LLC. | $139.28 | 2023-2025 | Nucala |
| Ars Pharmaceuticals Operations, INC. | $87.67 | 2025 | Neffy |
| Phathom Pharmaceuticals, INC. | $76.46 | 2024-2025 | Voquezna |
| Revance Therapeutics, INC. | $73.13 | 2024-2025 | Daxxify |
| Novartis Pharmaceuticals Corporation | $65.73 | 2022-2025 | |
| Stryker Corporation | $65.14 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $60.51 | 2020-2021 | |
| Kaleo, INC. | $23.56 | 2021 | |
| Abbvie INC. | $22.47 | 2024 | |
| Acclarent, INC | $20.05 | 2023 | Acclarent Aera |
| Greer Laboratories, INC. | $19.28 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $15.78 | 2025 | Inspire |
| Astrazeneca Pharmaceuticals LP | $14.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dale Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.